Bain Capital Private Equity

PE/Buy-Out · London (United Kingdom)

PE/Buy-Out

PE/Buy-out

AI

Cloud/SaaS

Sign up free to access full profile and submit your pitch.

About

Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Investment Criteria

Other investors that have backed the same portfolio companies as Bain Capital Private Equity. Expand any entry to see the shared portfolio companies.

• Bain Capital

  32 shared

  Shared portfolio companies

  • 360 One Wam Limited
  • Annexon, Inc.
  • Asia Pacific Medical Group Limited
  • ASIMCO Technologies Limited
  • Ataccama Corp.
  • athenahealth, Inc.
  • Axis Bank Limited
  • Beijing Avistone Biotechnology Co., Ltd.
  • Blackpoint Holdings, LLC
  • BRP Inc.
  • Cardurion Pharmaceuticals, Inc.
  • China PnR Mobile Payments Solutions Pvt. Ltd.
  • CitiusTech Inc.
  • CLASSYS Inc.
  • Coherent Corp.
  • Deltatre S.p.A.
  • F.I.S. - Fabbrica Italiana Sintetici S.p.A.
  • Frontline Road Safety Group, LLC
  • iManage LLC
  • Maesa
  • Nutanix, Inc.
  • OverIT S.p.A.
  • RSB Transmissions (I) Ltd.
  • Sdui GmbH
  • SO.MA.CI.S. S.p.A.
  • SumUp Payments Limited
  • The Weather Company, LLC
  • Tri-Stage Inc.
  • Waystar Holding Corp.
  • WinTriX DC Group
  • World Wide Packaging, LLC
  • X4 Pharmaceuticals, Inc.
• Bain Capital Life Sciences

  13 shared

  Shared portfolio companies

  • Annexon, Inc.
  • Beijing Avistone Biotechnology Co., Ltd.
  • Cardurion Pharmaceuticals, Inc.
  • Dianthus Therapeutics, Inc.
  • Dynavax Technologies Corporation
  • Kailera Therapeutics, Inc.
  • Kestra Medical Technologies, Ltd.
  • Mersana Therapeutics, Inc.
  • Rapid Micro Biosystems, Inc.
  • Solid Biosciences Inc.
  • Tango Therapeutics, Inc.
  • Tenacia Biotechnology (Shanghai) Co., Ltd.
  • X4 Pharmaceuticals, Inc.
• HarbourVest Partners LLC

  5 shared

  Shared portfolio companies

  • Blue (BC) BidCo Ltd
  • China PnR Mobile Payments Solutions Pvt. Ltd.
  • Lionbridge Financing Leasing (China) Co.,Ltd.
  • Nets Holding A/S
  • Zelis Healthcare Inc.
• New Enterprise Associates

  5 shared

  Shared portfolio companies

  • Annexon, Inc.
  • Cardurion Pharmaceuticals, Inc.
  • Mersana Therapeutics, Inc.
  • U.S. Renal Care, Inc.
  • X4 Pharmaceuticals, Inc.
• Advent International Corporation

  4 shared

  Shared portfolio companies

  • Ab Toscana (Luxembourg) Investment S.à R.L.
  • Imperial Dade Intermediate Holdings, LLC
  • Mercury UK Holdco Limited
  • Nexi Payments S.p.A.
• RA Capital Management

  4 shared

  Shared portfolio companies

  • Dianthus Therapeutics, Inc.
  • Solid Biosciences Inc.
  • Tango Therapeutics, Inc.
  • X4 Pharmaceuticals, Inc.
• Bain Capital Double Impact

  3 shared

  Shared portfolio companies

  • athenahealth, Inc.
  • E2 185 Bleecker LLC
  • Sparq Holdings, Inc.
• Bain Capital Ventures

  3 shared

  Shared portfolio companies

  • China PnR Mobile Payments Solutions Pvt. Ltd.
  • M/C Communications, LLC
  • Zelis Healthcare Inc.
• Battery Ventures LP

  3 shared

  Shared portfolio companies

  • Environmental Data Resources, LLC
  • Nutanix, Inc.
  • UpKeep Technologies, Inc.
• IFC Venture Capital

  3 shared

  Shared portfolio companies

  • Himadri Speciality Chemical Limited
  • Masan Group Corporation
  • RSB Transmissions (I) Ltd.